ABL1 | C-abl oncogene 1, non-receptor tyrosine kinase | Cancer-related genes Disease related genes Enzymes FDA approved drug targets RAS pathway related proteins
| | | ![](/images/27280/ihc_cell_selected_60x60.jpg) | ![](/images/28409/61493_B_9_3_rna_selected_60x60.jpg) | Expressed in all |
ADA | Adenosine deaminase | Disease related genes Enzymes FDA approved drug targets Plasma proteins
| | | ![](/images/4307/ihc_cell_selected_60x60.jpg) | ![](/images/23884/54930_B_9_3_rna_selected_60x60.jpg) | Tissue enriched |
ANO1 | Anoctamin 1, calcium activated chloride channel | FDA approved drug targets Plasma proteins Predicted membrane proteins Transporters
| | | ![](/images_static/rna_center.gif) | ![](/images/32148/77451_B_9_1_rna_selected_60x60.jpg) | Tissue enhanced |
ANXA1 | Annexin A1 | Cancer-related genes FDA approved drug targets Plasma proteins Transporters
| | | | ![](/images/11271/29845_B_1_8_rna_selected_60x60.jpg) | Expressed in all |
APEX1 | APEX nuclease (multifunctional DNA repair enzyme) 1 | Cancer-related genes Enzymes FDA approved drug targets Plasma proteins
| | | | ![](/images/2564/7318_B_9_3_rna_selected_60x60.jpg) | Expressed in all |
ATIC | 5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Plasma proteins
| | | ![](/images_static/rna_center.gif) | ![](/images/13462/28449_B_2_4_rna_selected_60x60.jpg) | Expressed in all |
BLVRB | Biliverdin reductase B (flavin reductase (NADPH)) | Enzymes FDA approved drug targets Plasma proteins Predicted secreted proteins
| | | | ![](/images/41937/90336_B_1_6_rna_selected_60x60.jpg) | Expressed in all |
CA4 | Carbonic anhydrase IV | Disease related genes Enzymes FDA approved drug targets Predicted membrane proteins Predicted secreted proteins
| | | ![](/images/17258/ihc_cell_selected_60x60.jpg) | ![](/images/11089/39733_B_8_2_rna_selected_60x60.jpg) | Tissue enhanced |
CAT | Catalase | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Plasma proteins
| | | ![](/images/1515/ihc_cell_selected_60x60.jpg) | ![](/images/55838/135651_B_8_2_rna_selected_60x60.jpg) | Expressed in all |
CD2 | CD2 molecule | CD markers FDA approved drug targets Predicted membrane proteins Predicted secreted proteins
| | | ![](/images/2430/ihc_cell_selected_60x60.jpg) | ![](/images/3883/11412_B_8_5_rna_selected_60x60.jpg) | Tissue enhanced |
CD4 | CD4 molecule | CD markers FDA approved drug targets Predicted membrane proteins Predicted secreted proteins
| | | ![](/images/11/ihc_cell_selected_60x60.jpg) | ![](/images/11/261_A_2_5_rna_selected_60x60.jpg) | Expressed in all |
CD44 | CD44 molecule (Indian blood group) | Blood group antigen proteins Cancer-related genes CD markers FDA approved drug targets Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | ![](/images/5785/16382_B_7_4_rna_selected_60x60.jpg) | Expressed in all |
CES1 | Carboxylesterase 1 | Enzymes FDA approved drug targets Plasma proteins Predicted secreted proteins
| | | ![](/images_static/rna_center.gif) | ![](/images/12023/30143_B_7_4_rna_selected_60x60.jpg) | Group enriched |
CPT1A | Carnitine palmitoyltransferase 1A (liver) | Disease related genes Enzymes FDA approved drug targets Mitochondrial proteins Plasma proteins Predicted membrane proteins
| | | | ![](/images/8835/24151_B_8_1_rna_selected_60x60.jpg) | Expressed in all |
CPT2 | Carnitine palmitoyltransferase 2 | Disease related genes Enzymes FDA approved drug targets Mitochondrial proteins Plasma proteins
| | | | ![](/images/28201/59343_B_9_2_rna_selected_60x60.jpg) | Expressed in all |
CYP51A1 | Cytochrome P450, family 51, subfamily A, polypeptide 1 | Enzymes FDA approved drug targets Predicted membrane proteins
| | | ![](/images_static/rna_center.gif) | ![](/images/41325/88210_B_9_2_rna_selected_60x60.jpg) | Expressed in all |
DHODH | Dihydroorotate dehydrogenase (quinone) | Disease related genes Enzymes FDA approved drug targets Mitochondrial proteins Predicted membrane proteins
| | | ![](/images_static/rna_center.gif) | ![](/images/10123/37043_B_8_5_rna_selected_60x60.jpg) | Expressed in all |
DNMT1 | DNA (cytosine-5-)-methyltransferase 1 | Disease related genes Enzymes FDA approved drug targets Plasma proteins Transcription factors
| | | | ![](/images/5876/14024_A_7_1_rna_selected_60x60.jpg) | Expressed in all |
DPEP1 | Dipeptidase 1 (renal) | Enzymes FDA approved drug targets Predicted secreted proteins
| | | ![](/images_static/rna_center.gif) | ![](/images/9426/25394_B_8_2_rna_selected_60x60.jpg) | Tissue enhanced |
EGFR | Epidermal growth factor receptor | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins Predicted secreted proteins RAS pathway related proteins
| | | | ![](/images/18530/41188_B_6_4_rna_selected_60x60.jpg) | Tissue enhanced |
ERBB2 | V-erb-b2 avian erythroblastic leukemia viral oncogene homolog 2 | Cancer-related genes CD markers Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | ![](/images_static/rna_center.gif) | ![](/images/20416/45830_B_7_8_rna_selected_60x60.jpg) | Expressed in all |
FASN | Fatty acid synthase | Cancer-related genes Enzymes FDA approved drug targets Plasma proteins
| | | | ![](/images/6461/17488_B_9_1_rna_selected_60x60.jpg) | Expressed in all |
FGF1 | Fibroblast growth factor 1 (acidic) | Cancer-related genes FDA approved drug targets RAS pathway related proteins
| | | ![](/images_static/rna_center.gif) | ![](/images/17519/39213_A_4_6_rna_selected_60x60.jpg) | Group enriched |
GANAB | Glucosidase, alpha; neutral AB | Enzymes FDA approved drug targets Plasma proteins Predicted secreted proteins
| | | | ![](/images/26874/57339_B_9_2_rna_selected_60x60.jpg) | Expressed in all |
GSR | Glutathione reductase | Cancer-related genes Enzymes FDA approved drug targets Mitochondrial proteins Plasma proteins
| | | | ![](/images/8632/26476_B_8_2_rna_selected_60x60.jpg) | Expressed in all |
HDAC1 | Histone deacetylase 1 | Enzymes FDA approved drug targets Plasma proteins
| | | | ![](/images/5017/18247_B_8_2_rna_selected_60x60.jpg) | Expressed in all |
HDAC2 | Histone deacetylase 2 | Cancer-related genes Enzymes FDA approved drug targets Plasma proteins
| | | | ![](/images/5054/17524_B_8_5_rna_selected_60x60.jpg) | Expressed in all |
HDAC3 | Histone deacetylase 3 | Enzymes FDA approved drug targets
| | | ![](/images_static/rna_center.gif) | ![](/images/5583/18272_B_7_2_rna_selected_60x60.jpg) | Expressed in all |
HDAC6 | Histone deacetylase 6 | Disease related genes Enzymes FDA approved drug targets Predicted membrane proteins
| | | ![](/images/3714/ihc_cell_selected_60x60.jpg) | ![](/images/26321/57610_A_3_2_rna_selected_60x60.jpg) | Expressed in all |
HMMR | Hyaluronan-mediated motility receptor (RHAMM) | CD markers FDA approved drug targets
| | | ![](/images_static/rna_center.gif) | ![](/images/2433/6865_B_8_6_rna_selected_60x60.jpg) | Mixed |
IKBKB | Inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta | Disease related genes Enzymes FDA approved drug targets Plasma proteins RAS pathway related proteins
| | | ![](/images/1249/ihc_cell_selected_60x60.jpg) | ![](/images/4447/13182_B_9_1_rna_selected_60x60.jpg) | Expressed in all |
ITGA2B | Integrin, alpha 2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41) | Cancer-related genes Candidate cardiovascular disease genes CD markers Disease related genes FDA approved drug targets Plasma proteins Predicted membrane proteins
| | | ![](/images_static/rna_center.gif) | ![](/images/31168/73887_B_8_1_rna_selected_60x60.jpg) | Tissue enhanced |
ITGB1 | Integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12) | Cancer-related genes CD markers FDA approved drug targets Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | ![](/images/3434/9046_B_7_8_rna_selected_60x60.jpg) | Expressed in all |
JUN | Jun proto-oncogene | Cancer-related genes FDA approved drug targets Transcription factors
| | | | ![](/images/3801/10119_B_2_4_rna_selected_60x60.jpg) | Expressed in all |
MAP2 | Microtubule-associated protein 2 | FDA approved drug targets Plasma proteins
| | | | ![](/images/1984/5294_A_2_8_rna_selected_60x60.jpg) | Tissue enriched |
MAP2K1 | Mitogen-activated protein kinase kinase 1 | Cancer-related genes Disease related genes Enzymes FDA approved drug targets RAS pathway related proteins
| | | ![](/images/26430/ihc_cell_selected_60x60.jpg) | ![](/images/3834/10782_A_2_6_rna_selected_60x60.jpg) | Expressed in all |
MAP2K2 | Mitogen-activated protein kinase kinase 2 | Cancer-related genes Disease related genes Enzymes FDA approved drug targets RAS pathway related proteins
| | | | ![](/images/3835/11076_B_9_1_rna_selected_60x60.jpg) | Expressed in all |
MAP4 | Microtubule-associated protein 4 | FDA approved drug targets Plasma proteins
| | | ![](/images_static/rna_center.gif) | ![](/images/38150/84142_B_1_4_rna_selected_60x60.jpg) | Expressed in all |
MAPK1 | Mitogen-activated protein kinase 1 | Cancer-related genes Cytoskeleton related proteins Enzymes FDA approved drug targets Plasma proteins RAS pathway related proteins
| | | ![](/images_static/rna_center.gif) | ![](/images/5700/20814_B_8_1_rna_selected_60x60.jpg) | Expressed in all |
MAPK3 | Mitogen-activated protein kinase 3 | Cancer-related genes Cytoskeleton related proteins Enzymes FDA approved drug targets RAS pathway related proteins
| | | ![](/images/2683/ihc_cell_selected_60x60.jpg) | ![](/images/5700/20814_B_7_4_rna_selected_60x60.jpg) | Expressed in all |
METAP2 | Methionyl aminopeptidase 2 | Enzymes FDA approved drug targets Plasma proteins
| | | ![](/images_static/rna_center.gif) | ![](/images/13025/28837_B_8_1_rna_selected_60x60.jpg) | Expressed in all |
NFKB1 | Nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 | Cancer-related genes FDA approved drug targets Plasma proteins RAS pathway related proteins Transcription factors
| | | | ![](/images/4031/11359_A_8_5_rna_selected_60x60.jpg) | Expressed in all |
NR3C1 | Nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) | Disease related genes FDA approved drug targets Nuclear receptors Plasma proteins Transcription factors
| | | | ![](/images/4248/13405_B_8_2_rna_selected_60x60.jpg) | Expressed in all |
PAH | Phenylalanine hydroxylase | Disease related genes Enzymes FDA approved drug targets
| | | ![](/images_static/rna_center.gif) | ![](/images/28407/59771_B_9_2_rna_selected_60x60.jpg) | Tissue enhanced |
PLA2G4A | Phospholipase A2, group IVA (cytosolic, calcium-dependent) | Disease related genes Enzymes FDA approved drug targets RAS pathway related proteins
| | | ![](/images_static/rna_center.gif) | ![](/images/10050/28034_B_9_2_rna_selected_60x60.jpg) | Mixed |
PLIN3 | Perilipin 3 | FDA approved drug targets Plasma proteins
| | | | ![](/images/6427/18235_B_7_8_rna_selected_60x60.jpg) | Expressed in all |
POLA1 | Polymerase (DNA directed), alpha 1, catalytic subunit | Enzymes FDA approved drug targets
| | | ![](/images/2947/ihc_cell_selected_60x60.jpg) | ![](/images/2947/8235_A_7_4_rna_selected_60x60.jpg) | Expressed in all |
PRDX5 | Peroxiredoxin 5 | Enzymes FDA approved drug targets Mitochondrial proteins Plasma proteins
| | | | ![](/images/8661/22812_B_9_1_rna_selected_60x60.jpg) | Expressed in all |
PRKAA1 | Protein kinase, AMP-activated, alpha 1 catalytic subunit | Enzymes FDA approved drug targets
| | | ![](/images_static/rna_center.gif) | ![](/images/5050/17832_B_9_1_rna_selected_60x60.jpg) | Expressed in all |
PRKAB1 | Protein kinase, AMP-activated, beta 1 non-catalytic subunit | FDA approved drug targets
| | | | ![](/images/5058/13154_B_7_2_rna_selected_60x60.jpg) | Expressed in all |